For a period, there was a shortage of the Novo Nordisk drug Wegovy. This is no longer the case, according to the US Food and Drug Administration, the FDA. (Archive photo). Photo: Scott Olson/Ritzau Scanpix
Novo Nordisk wins US copycat drug lawsuit
Pharmaceutical companies Novo Nordisk and Eli Lilly, alongside the US FDA, have won an appeals case in the US confirming that their diabetes and obesity drugs are no longer in shortage.
The appeals court ruled that the FDA followed the correct procedure in reaching this conclusion. The opposing...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?